In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Simcere Pharmaceutical Group

www.simcere.com

Latest From Simcere Pharmaceutical Group

Deal Watch: Another Delay For Roche/Spark, While FTC Ups AbbVie/Allergan Merger Scrutiny

Tender deadline for Roche acquisition of Spark pushed back to 30 October; 21.4% of Spark shares tendered so far. Vertex further diversifies with fourth deal of 2019 – an RNA-targeted collaboration with Ribometrix.

Deals M & A

Asia Deal Watch: ASLAN, Bukwang Establish Immuno-Oncology JV In Singapore

The JV to be called JAGUAHR Therapeutics will focus on the AhR pathway. Simcere acquires Chinese rights to JW’s gout candidate.

Deals Business Strategies

Asia Executives On The Move: Senior Level Changes At Pfizer Upjohn, Simcere In China

The change of seasons sees a flurry of senior level executive changes taking place across the Asia Pacific health sector. Appointments include a new GM at Pfizer Upjohn China while Sanofi Japan has a new specialty business head and Lupin changes its US head. 
Appointments Asia Pacific

Asia Executives On The Move: Returners And Leavers At Merck; Changes At Takeda, Ono, Simcere And More

Merck China former R&D head returns after a short stint with startup Ascletis, and Takeda has a new center director for commercial health. Top executives change also take place at Ono in Korea and Simcere Pharma.

Asia Pacific Appointments
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
    • Vaccines
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Parent & Subsidiaries
  • Simcere Pharmaceutical Group
  • Senior Management
  • Jinsheng Ren, CEO
    Wan Yushan, CFO
    Hua Mu, MD, PhD, CSO
  • Contact Info
  • Simcere Pharmaceutical Group
    Phone: (86) 025 855 66666
    699-18 Xuanwu Ave.
    Nanjing, 210042
    China
Advertisement
Advertisement
UsernamePublicRestriction

Register